GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
4,452
Funds Holding Change
+36
Funds Holding Growth
+0.8%
Value
$990B
Holding in Top 10
606
Top 10 Change
+48
Top 10 Growth
+9%
Value Growth
+9%
New
217
Increased
1,994
Reduced
1,918
Closed
141
Capital Inflow
$28.5B
Capital Outflow
$34.8B
Net Capital Flow
-$6.33B
Capital Flow Change
-$19.5B
Calls
$12.1B
Puts
$12.1B
Net Calls
-$19M
Put/Call Ratio
1